{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:52:31Z","timestamp":1787676751468,"version":"build-2784847793"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>We provide an overview of recent articles which describe new thinking regarding HLA-B27-associated reactive arthritis (ReA), including those additional infection-related arthritides triggered by microbes that often are grouped under the term ReA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>With the advent and continuation of the pandemic, an increasing number of cases and case series of post-COVID-19 arthritis have been reported and classified as ReA. Further, arthritis after COVID-19 vaccination is a new entity included within the spectrum of ReA. New causative microorganisms identified in case reports include <jats:italic toggle=\"yes\">Clostridium difficile, Mycoplasma pneumoniae, Giardia lamblia, Leptospira<\/jats:italic>, and babesiosis. SARS-CoV-2 is emerging as a significant etiologic agent for apparent ReA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>It is now clear that comprehensive clinical and laboratory investigations, synovial fluid analyses, and close follow-up of patients all are essential to differentiate ReA from diseases that may present with similar clinical attributes. Further, and importantly, additional research is required to define the wide diversity in causative agents, epidemiology, and rare case presentations of these arthritides. Finally, new classification and diagnostic criteria, and updated treatment recommendations, are essential to the advancement of our understanding of ReA.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000880","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T13:01:45Z","timestamp":1655211705000},"page":"218-224","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Quo vadis reactive arthritis?"],"prefix":"10.1097","volume":"34","author":[{"given":"Henning","family":"Zeidler","sequence":"first","affiliation":[{"name":"Clinic of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Hudson","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Microbiology, and Immunology, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00002281-200007000-00012","article-title":"Reactive arthritis","volume":"12","author":"Toivanen","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/BOR.0b013e32833a43a2","article-title":"The evolving story of Chlamydia-induced reactive arthritis","volume":"22","author":"Carter","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/BOR.0b013e328337ba26","article-title":"Acute rheumatic fever and poststreptococcal reactive arthritis reconsidered","volume":"22","author":"van der Helm-van","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00296-017-3779-1","article-title":"Incidence of inflammatory joint diseases in Finland: results from a population-based epidemiological study","volume":"37","author":"Kononoff","year":"2017","journal-title":"Rheumatol Int"},{"key":"R5-20250526","first-page":"1","article-title":"Reactive arthritis: update","author":"Bentaleb","year":"2020","journal-title":"Curr Clin Microbiol Rep"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"660","DOI":"10.55563\/clinexprheumatol\/yycy0o","article-title":"Incidence of spondyloarthritis and its subtypes: a systematic review","volume":"39","author":"Alamanos","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/fpd.2020.2910","article-title":"Enteric pathogens and reactive arthritis: systematic review and meta-analyses of pathogen-associated reactive arthritis","volume":"18","author":"Pogreba-Brown","year":"2021","journal-title":"Foodborne Pathog Dis"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"e996","DOI":"10.1093\/milmed\/usaa518","article-title":"Yersinia enterocolitica: a follow-up of the outbreak in the Norwegian Armed Forces in 2014","volume":"186","author":"Borud","year":"2021","journal-title":"Mil Med"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/annrheumdis-2019-216736","article-title":"Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli","volume":"79","author":"Tuompo","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s10067-016-3364-0","article-title":"The incidence of sexually acquired reactive arthritis: a systematic literature review","volume":"35","author":"Denison","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11926-019-0863-4","article-title":"Chlamydia-induced reactive arthritis: disappearing entity or lack of research?","volume":"21","author":"Zeidler","year":"2019","journal-title":"Curr Rheumatol Rep"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11926-021-01018-6","article-title":"Reactive arthritis update: spotlight on new and rare infectious agents implicated as pathogens","volume":"23","author":"Zeidler","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.reuma.2016.08.001","article-title":"Evolution over thirty years of the profile of inpatients with reactive arthritis in a tertiary rheumatology unit","volume":"14","author":"Brinster","year":"2018","journal-title":"Reumatol Clin"},{"key":"R14-20250526","first-page":"e9698","article-title":"Reactive arthritis in a 37-year-old female with SARS-CoV2 infection","volume":"12","author":"Danssaert","year":"2020","journal-title":"Cureus"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/RHU.0000000000001560","article-title":"A case of reactive arthritis secondary to coronavirus disease infection","volume":"26","author":"Liew","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10067-018-4022-5","article-title":"Reactive arthritis: update 2018","volume":"37","author":"Garc\u00eda-Kutzbach","year":"2018","journal-title":"Clin Rheumatol"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/1744666X.2017.1233816","article-title":"Recent advances and future directions in understanding and treating Chlamydia-induced reactive arthritis","volume":"13","author":"Carter","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.idc.2017.01.002","article-title":"Reactive arthritis","volume":"31","author":"Schmitt","year":"2017","journal-title":"Infect Dis Clin N Am"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/1529-0131(200107)44:7<1689::AID-ART293>3.0.CO;2-K","article-title":"Chromosomal DNA from a variety of bacterial species is present in synovial tissue in patients with various forms of arthritis","volume":"44","author":"G\u00e9rard","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/microorganisms8040482","article-title":"Novel clinical Campylobacter jejuni infection models based on sensitization of mice to lipooligosaccharide, a major bacterial factor triggering innate immune responses in human campylobacteriosis","volume":"8","author":"Mousave","year":"2020","journal-title":"Microorganisms"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41584-018-0097-2","article-title":"The microbiome and HLA-B27-associated acute anterior uveitis","volume":"14","author":"Rosenbaum","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.40359","article-title":"Gut microbiota perturbations in reactive arthritis and postinfectious spondyloarthritis","volume":"70","author":"Manasson","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"15131","DOI":"10.1038\/s41598-020-71674-8","article-title":"Elucidating potential molecular signatures through host-microbe interactions for reactive arthritis and inflammatory bowel disease using combinatorial approach","volume":"10","author":"Verma","year":"2020","journal-title":"Sci Rep"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"e24316","DOI":"10.1097\/MD.0000000000024316","article-title":"Arthritis associated with Mycoplasma pneumoniae in a pediatric patient: a case report","volume":"100","author":"M\u0103rginean","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"e240890","DOI":"10.1136\/bcr-2020-240890","article-title":"Reactive arthritis: an unusual presentation of acute Clostridioides difficile colitis","volume":"14","author":"Reinholz","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s10067-005-0085-1","article-title":"Juvenile spondyloarthropathies associated with Mycoplasma pneumoniae infection","volume":"25","author":"Harjacek","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13256-020-02479-6","article-title":"Chronic seronegative spondyloarthropathy following acute Mycoplasma pneumoniae infection in a human leukocyte antigen B27-positive patient: a case report","volume":"14","author":"Pilianidis","year":"2020","journal-title":"J Med Case Rep"},{"key":"R28-20250526","first-page":"79","article-title":"Case report of a rare cause of reactive arthritis: leptospirosis","volume":"11","author":"Dey","year":"2021","journal-title":"J Orthop Case Rep"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"031","DOI":"10.14411\/fp.2020.031","article-title":"The first human case of babesiosis mimicking Reiter's syndrome","volume":"67","author":"Strizova","year":"2020","journal-title":"Folia Parasitol (Praha)"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1002\/jmv.27229","article-title":"SARS-CoV2-triggered acute arthritis: viral arthritis rather than reactive arthritis","volume":"93","author":"Kobayashi","year":"2021","journal-title":"J Med Virol"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s10067-021-05691-x","article-title":"COVID-19 and the clinical course of rheumatic manifestations","volume":"40","author":"Ahmed","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00393-021-01045-9","article-title":"Post-COVID-19-arthritis. Manifestation unter dem klinischen Bild einer reaktiven Arthritis [Post-corona-virus-disease-19 arthritis. Manifestation under the clinical picture of a reactive arthritis]","volume":"80","author":"Zeidler","year":"2021","journal-title":"Z Rheumatol"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1007\/s10067-020-05550-1","article-title":"Post-COVID-19 arthritis: a case report and literature review","volume":"40","author":"Gasparotto","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"105086","DOI":"10.1016\/j.jbspin.2020.105086","article-title":"Can SARS-CoV-2 trigger reactive arthritis?","volume":"88","author":"Wendling","year":"2021","journal-title":"Joint Bone Spine"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/v13081558","article-title":"Post-COVID-19 arthritis and sacroiliitis: natural history with longitudinal magnetic resonance imaging study in two cases and review of the literature","volume":"13","author":"Colatutto","year":"2021","journal-title":"Viruses"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00296-021-04998-x","article-title":"Reactive arthritis after COVID-19: a case-based review","volume":"41","author":"Kocyigit","year":"2021","journal-title":"Rheumatol Int"},{"key":"R37-20250526","first-page":"e18620","article-title":"Extra-articular manifestations in reactive arthritis due to COVID-19","volume":"13","author":"Santacruz","year":"2021","journal-title":"Cureus"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/09564624211020266","article-title":"British Association of Sexual Health and HIV national guideline on the management of sexually acquired reactive arthritis 2021","volume":"32","author":"Carlin","year":"2021","journal-title":"Int J STD AIDS"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4997\/jrcpe.2021.319","article-title":"Reactive arthritis: a clinical review","volume":"51","author":"Jubber","year":"2021","journal-title":"J R Coll Physicians Edinb"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00296-021-04879-3","article-title":"Expanding the spectrum of reactive arthritis (ReA): classic ReA and infection-related arthritis including poststreptococcal ReA, Poncet's disease, and iBCG-induced ReA","volume":"41","author":"Taniguchi","year":"2021","journal-title":"Rheumatol Int"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/art.27394","article-title":"Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial","volume":"62","author":"Carter","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R42-20250526","first-page":"47","article-title":"The pattern of postviral arthritis in COVID pandemic state: an experience of tertiary care centre","volume":"69","author":"Jaladhar","year":"2021","journal-title":"J Assoc Physicians India"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:17:03Z","timestamp":1748294223000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000880","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]}}}